Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.39 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.39 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.38 |
| ▸ | KDM4C | Q9H3R0 | 3/20 | 0.37 |
| ▸ | KDM5A | P29375 | 3/20 | 0.37 |
| ▸ | PHF8 | Q9UPP1 | 3/20 | 0.37 |
| ▸ | KDM2A | Q9Y2K7 | 3/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.36 |
| ▸ | KDM4A | O75164 | 1/20 | 0.36 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5118077 | 1.00 | MEN1 (0.59) | MEN1KMT2AALDH1A1LMNATSHR | |
| SCHEMBL1532127 | 1.00 | MEN1 (0.59) | MEN1KMT2AALDH1A1LMNATSHR | |
| SCHEMBL27200192 | 1.00 | MEN1 (0.59) | MEN1KMT2AALDH1A1LMNATSHR | |
| SCHEMBL10518204 | 1.00 | MEN1 (0.59) | MEN1KMT2AALDH1A1LMNATSHR | |
| SCHEMBL29172381 | 1.00 | MEN1 (0.59) | MEN1KMT2AALDH1A1LMNATSHR | |
| SCHEMBL6526800 | 1.00 | MEN1 (0.59) | MEN1KMT2AALDH1A1LMNATSHR | |
| SCHEMBL11577255 | 1.00 | MEN1 (0.59) | MEN1KMT2AALDH1A1LMNATSHR | |
| SCHEMBL29148468 | 1.00 | MEN1 (0.59) | MEN1KMT2AALDH1A1LMNATSHR | |
| SCHEMBL24776345 | 0.95 | MEN1 (0.57) | MEN1KMT2AALDH1A1LMNATSHR | |
| SCHEMBL31615036 | 0.92 | KMT2A (0.52) | MEN1KMT2ALMNATBXA2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4182737-B1 | OPTICALLY ACTIVE DEVICES | AMO Ireland (IE) | 2024-07-03 | — | — | EP | disclosed |
| EP-4182737-B1 | OPTICALLY ACTIVE DEVICES | AMO Ireland (IE) | 2024-07-03 | — | — | EP | disclosed |
| CN-118256591-A | Cyclic peptide compound having high membrane permeability and library comprising same | 中外制药株式会社 | 2024-06-28 | — | — | CN | disclosed |
| CN-118184532-A | Amino acid having functional group capable of forming intramolecular hydrogen bond, peptide compound containing the amino acid, and process for producing the same | 中外制药株式会社 | 2024-06-14 | — | — | CN | disclosed |
| CN-113454058-B | Amino acid having functional group capable of forming intramolecular hydrogen bond, peptide compound containing the amino acid, and process for producing the same | 中外制药株式会社 | 2024-03-22 | — | — | CN | disclosed |
| CN-110869544-B | Cyclic peptide compound having high membrane permeability and library comprising same | 中外制药株式会社 | 2024-03-08 | — | — | CN | disclosed |
| US-20230273455-A1 | OPTICALLY ACTIVE DEVICES | JOHNSON & JOHNSON SURGICAL VISION INC (US) | 2023-08-31 | — | — | US | disclosed |
| US-20230273455-A1 | OPTICALLY ACTIVE DEVICES | JOHNSON & JOHNSON SURGICAL VISION INC (US) | 2023-08-31 | — | — | US | disclosed |
| US-20230273456-A1 | OPTICALLY ACTIVE DEVICES | JOHNSON & JOHNSON SURGICAL VISION INC (US) | 2023-08-31 | — | — | US | disclosed |
| US-20230273456-A1 | OPTICALLY ACTIVE DEVICES | JOHNSON & JOHNSON SURGICAL VISION INC (US) | 2023-08-31 | — | — | US | disclosed |
| WO-2022012799-A1 | OPTICALLY ACTIVE DEVICES | MERCK PATENT GMBH (DE) | 2022-01-20 | — | — | WO | disclosed |
| US-20090221442-A1 | SUBSTRATES AND SCREENING METHODS FOR TRANSPORT PROTEINS | XENOPORT, INC. (US) | 2009-09-03 | — | — | US | disclosed |
| US-20090221442-A1 | SUBSTRATES AND SCREENING METHODS FOR TRANSPORT PROTEINS | XENOPORT, INC. (US) | 2009-09-03 | — | — | US | disclosed |
| US-7413536-B1 | Substrates and screening methods for transport proteins | XENOPORT, INC. (US) | 2008-08-19 | — | — | US | disclosed |
| EP-1212619-B1 | SUBSTRATES AND SCREENING METHODS FOR TRANSPORT PROTEINS | XENOPORT INC (US) | 2007-05-23 | — | — | EP | disclosed |
| EP-1212619-A4 | SUBSTRATES AND SCREENING METHODS FOR TRANSPORT PROTEINS | XENOPORT INC (US) | 2004-12-08 | — | — | EP | disclosed |
| WO-2001020331-A9 | SUBSTRATES AND SCREENING METHODS FOR TRANSPORT PROTEINS | XENOPORT INC (US) | 2002-10-03 | — | — | WO | disclosed |
| EP-1212619-A1 | SUBSTRATES AND SCREENING METHODS FOR TRANSPORT PROTEINS | Xenoport, Inc. (US) | 2002-06-12 | — | — | EP | disclosed |
| WO-2001020331-A1 | SUBSTRATES AND SCREENING METHODS FOR TRANSPORT PROTEINS | XENOPORT, INC. (US) | 2001-03-22 | — | — | WO | disclosed |
| EP-0270234-A2 | Renin inhibitors | PFIZER INC. (US) | 1988-06-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230273456-A1 | OPTICALLY ACTIVE DEVICES | PDE6C, PDE6D, PDE6A | MEN1 3047/4885KMT2A 3838/4885ALDH1A1 277/4885 |
| US-20230273455-A1 | OPTICALLY ACTIVE DEVICES | PDE6C, PDE6A, PDE6D | MEN1 3042/4885KMT2A 4011/4885ALDH1A1 311/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.